SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as investors debate the potential for a transformative buyout following reports of massive pharmaceutical M&A activity in the oncology space. Community discussions are highly polarized, with bulls highlighting the trial's prolonged survival timeline as evidence of therapeutic success, while bears express concern over the company's financial structure and the potential for a binary clinical outcome.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is generating intense community speculation as investors anticipate imminent Phase 3 VELA data, fueling intense M&A discussions and optimism that sonelokimab will emerge as a best-in-class treatment for hidradenitis suppurativa. The community is closely watching for a potential data release to coincide with upcoming investor presentations, which many believe could trigger a massive rerating event due to the drug's demonstrated efficacy and superior safety profile over existing competition.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is trending as market participants closely monitor geopolitical tensions in the Middle East and their potential impact on energy markets and interest rate sentiment. The community is actively debating the durability of the AI-driven tech rally amidst record market highs and ongoing economic uncertainty.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk Corp (SNDK) is witnessing extreme volatility and a parabolic rally, fueled by intense investor enthusiasm surrounding AI-driven memory storage demands and persistent supply chain bottlenecks. The stock has become a primary focal point for momentum traders, sparking heated debates between bulls banking on a structural supercycle and bears warning of a speculative bubble due to its rapid, historic price appreciation.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is attracting intense investor attention following a significant clinical data release for Lupkynis and increased share accumulation by CEO Kevin Tang. While the community is actively debating the potential for an imminent buyout or strategic acquisition, sentiment remains divided between hopeful longs anticipating a catalyst-driven surge and skeptics frustrated by a lack of direct management communication.

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Butterfly Network Inc - Ordinary Shares - Class A

Butterfly Network Inc

Butterfly Network is experiencing significant volatility and social media attention following an announcement regarding a co-development deal with Midjourney, which investors are analyzing as a potential long-term catalyst for the company's semiconductor-based ultrasound technology. While bulls highlight institutional backing and the transformative potential of AI in medical imaging, bears are actively debating the high valuation, persistent cash burn, and the risk of a share offering following the rapid price move.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending following the announcement of a joint research agreement with Honda, which confirms that another major OEM has validated the company's solid-state battery technology after rigorous testing. The community is actively debating the significance of this partnership, weighing the long-term potential of the technology against frustrations over the lack of immediate commercial-scale revenue.

Keel Infrastructure Corp. engages in building artificial intelligence focused data centers and energy assets. It focuses on infrastructure and energy required to support high-performance computing and artificial intelligence workloads. The company was founded on April 1, 2026 and is headquartered in New York, NY.

Keel Infrastructure Corp.

Keel Infrastructure Corp

Keel Infrastructure Corp. is generating significant buzz as investors anticipate potential data center lease announcements and structural growth within the AI infrastructure sector. Community discourse is currently split between bullish sentiment fueled by pipeline progress and institutional interest, and skeptical commentary regarding the firm's lack of signed contracts and current profitability.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Invesco QQQ Trust remains a focal point for investors as the community debates the sustainability of the AI-driven market rally against the backdrop of heightened geopolitical tensions in the Middle East and ongoing trade negotiations. Traders are closely monitoring the interplay between speculative options activity, earnings expectations, and potential shifts in macroeconomic policy.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

SPY is experiencing heightened volatility as market participants weigh conflicting geopolitical headlines regarding Iran and ongoing negotiations over the Strait of Hormuz. Community sentiment is deeply divided, with traders closely monitoring institutional flows and technical support levels while reacting to the frequent release of market-moving news updates.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nature's Sunshine Products (NATR) Expected to Announce Earnings on Thursday

Nature's Sunshine Products (NASDAQ:NATR) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at...

Nature's Sunshine Products (NASDAQ:NATR) Shares Pass Above 200-Day Moving Average - What's Next?

Nature's Sunshine Products (NASDAQ:NATR) Shares Cross Above 200-Day Moving Average - Here's Why...

Daniel Norman Sells 15,383 Shares of Nature's Sunshine Products (NASDAQ:NATR) Stock

Nature's Sunshine Products, Inc. (NASDAQ:NATR - Get Free Report) EVP Daniel Norman sold 15,383 shares of the firm's stock in a transaction dated Friday, March 13th. The stock was sold at an average...

Insider Selling: Nature's Sunshine Products (NASDAQ:NATR) EVP Sells 19,516 Shares of Stock

Nature's Sunshine Products, Inc. (NASDAQ:NATR - Get Free Report) EVP Bryant Yates sold 19,516 shares of the firm's stock in a transaction on Friday, March 13th. The shares were sold at an average...

Insider Selling: Nature's Sunshine Products (NASDAQ:NATR) EVP Sells 15,383 Shares of Stock

Nature's Sunshine Products, Inc. (NASDAQ:NATR - Get Free Report) EVP Daniel Norman sold 15,383 shares of the company's stock in a transaction dated Friday, March 13th. The shares were sold at an...

Nature's Sunshine Products (NASDAQ:NATR) CAO Sells $98,800.00 in Stock

Nature's Sunshine Products, Inc. (NASDAQ:NATR - Get Free Report) CAO Jonathan David Lanoy sold 4,000 shares of Nature's Sunshine Products stock in a transaction that occurred on Friday, March 13th...

Nature's Sunshine Products (NASDAQ:NATR) CAO Jonathan David Lanoy Sells 4,000 Shares

Nature's Sunshine Products (NASDAQ:NATR) Price Target Raised to $33.00 at DA Davidson

DA Davidson raised their price target on shares of Nature's Sunshine Products from $23.00 to $33.00 and gave the company a "buy" rating in a research note on Thursday...

Nature's Sunshine Products Q4 Earnings Call Highlights

Nature's Sunshine Products (NASDAQ:NATR) reported fourth-quarter and full-year 2025 results that management described as record-setting, citing continued momentum in its digital business, increased...

Earnings Summary: Natures Sunshine Products Q4

Nature's Sunshine Products, Inc. engages in the manufacture and sale of nutritional and personal care products. Its product lines include general health, immune, cardiovascular, digestive, personal care, and weight management. It operates through the following geographical segments: Asia, Europe, North America, and Latin America and Other. The company was founded by Eugene L. Hughes, Kristine F. Hughes, and Pauline Hughes-Francis in 1972 and is headquartered in Lehi, UT.

Nature`s Sunshine Products, Inc.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$20.12
Prev Close	$20.08
Open	$20.19
Dividend Yield	0.00%
50-Day Moving Average	$23.50
Beta	0.54
Avg. Volume	117,537.07
PE Ratio	18.43

52-Week High	$28.14
52-Week Low	$12.97
Market Capitalization	$353.81M
EPS (Annual)	$1.06
Price to Book	2.12
Revenue Per Employee	$595,712.16

NATRNature`s Sunshine Products, Inc.

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NATR News